Literature Collection

Magnifying Glass
Collection Insights

11K+

References

9K+

Articles

1500+

Grey Literature

4600+

Opioids & SU

The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Enter Search Term(s)
Year
Sort by
Order
Show
11272 Results
3081
Diagnosing somatisation disorder (P75) in routine general practice using the International Classification of Primary Care
Type: Journal Article
Authors: Rainer Schaefert, Gunter Laux, Claudia Kaufmann, Dieter Schellberg, Regine Bolter, Joachim Szecsenyi, Nina Sauer, Wolfgang Herzog, Thomas Kuehlein
Year: 2010
Publication Place: United States
Topic(s):
Medically Unexplained Symptoms See topic collection
3082
Diagnosis and treatment of depression in adults with comorbid medical conditions: A 52-year-old man with depression
Type: Journal Article
Authors: M. A. Whooley
Year: 2012
Publication Place: United States
Abstract: Approximately 1 in 10 primary care patients has major depressive disorder, and its presence is associated with poor health outcomes in numerous medical conditions. Using the case of Mr J, a 52-year-old man with depressive symptoms and several comorbid medical conditions, diagnosis and treatment of depression are discussed. Specific topics include evidence regarding appropriate depression screening and diagnosis, the importance of team-based care, patient self-management, exercise, structured psychotherapy, pharmacotherapy, monitoring of therapy, and indications for referral.
Topic(s):
General Literature See topic collection
3083
Diagnosis and treatment of patients with comorbid substance use disorder and adult attention-deficit and hyperactivity disorder: a review of recent publications
Type: Journal Article
Authors: D. van der Burg, C. L. Crunelle, F. Matthys, W. van den Brink
Year: 2019
Publication Place: United States
Abstract:

PURPOSE OF REVIEW: Attention-deficit and hyperactivity disorder (ADHD) often presents with comorbid substance use disorders (SUD). Due to similarities in key symptoms of both disorders and suboptimal efficacy of the available treatments, clinicians are faced with difficulties in the diagnosis and treatment of these patients with both disorders. This review addresses recent publications between 2017 and 2019 on the etiology, prevalence, diagnosis and treatment of co-occurring ADHD and SUD. RECENT FINDINGS: ADHD is diagnosed in 15-20% of SUD patients, mostly as ADHD with combined (hyperactive/inattentive) presentation. Even during active substance use, screening with the Adult ADHD Self-Report Scale (ASRS) is useful to address whether further diagnostic evaluation is needed. After SUD treatment, the diagnosis of ADHD generally remains stable, but ADHD subtype presentations are not. Some evidence supports pharmacological treatment with long-acting stimulants in higher than usual dosages. Studies on psychological treatment remain scarce, but there are some promising findings on integrated cognitive behaviour therapy. SUMMARY: Diagnosis and treatment of patients with comorbid ADHD and SUD remain challenging. As ADHD presentations can change during active treatment, an active follow-up is warranted to provide treatment to the individuals' personal strengths and weaknesses.

Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Measures See topic collection
,
Opioids & Substance Use See topic collection
3085
Diagnosis of mental illness in primary and secondary care with a focus on bipolar disorder.
Type: Journal Article
Authors: Jonathan Rogers, Mark Agius, Rashid Zaman
Year: 2012
Publication Place: Croatia
Topic(s):
Education & Workforce See topic collection
3087
Diagnosis of somatisation: effect of an educational intervention in a cluster randomised controlled trial
Type: Journal Article
Authors: M. Rosendal, F. Bro, P. Fink, K. S. Christensen, F. Olesen
Year: 2003
Publication Place: England
Abstract: BACKGROUND: Somatisation is highly prevalent in primary care (present in 25% of visiting patients) but often goes unrecognised. Non-recognition may lead to ineffective treatment, risk of iatrogenic harm, and excessive use of healthcare services. AIM: To examine the effect of training on diagnosis of somatisation in routine clinical practice by general practitioners (GPs). DESIGN OF STUDY: Cluster randomised controlled trial, with practices as the randomisation unit. SETTING: Twenty-seven general practices (with a total of 43 GPs) in Vejle County, Denmark. METHOD: Intervention consisted of a multifaceted training programme (the TERM [The Extended Reattribution and Management] model). Patients were enrolled consecutively over a period of 13 working days. Psychiatric morbidity was assessed by means of a screening questionnaire. GPs categorised their diagnoses in another questionnaire. The primary outcome was GP diagnosis of somatisation and agreement with the screening questionnaire. RESULTS: GPs diagnosed somatisation less frequently than had previously been observed, but there was substantial variation between GPs. The difference between groups in the number of diagnoses of somatisation failed to reach the 5% significance (P = 0.094). However, the rate of diagnoses of medically unexplained physical symptoms was twice as high in the intervention group as in the control group (7.7% and 3.9%, respectively, P = 0.007). Examination of the agreement between GPs' diagnoses and the screening questionnaire revealed no significant difference between groups. CONCLUSION: Brief training increased GPs' awareness of medically unexplained physical symptoms. Diagnostic accuracy according to a screening questionnaire remained unaffected but was difficult to evaluate, as there is no agreement on a gold standard for somatisation in general practice.
Topic(s):
Medically Unexplained Symptoms See topic collection
3088
Diagnosis of somatoform disorders in primary care: Diagnostic agreement, predictors, and comaprisons with depression and anxiety
Type: Journal Article
Authors: Katharina Piontek, Meike Shedden-Mora, Maria Gladigau, Amina Kuby, Bernd Lowe
Year: 2018
Topic(s):
Education & Workforce See topic collection
,
Medically Unexplained Symptoms See topic collection
3089
Diagnostic accuracy and adequacy of treatment of depressive and anxiety disorders: A comparison of primary care and specialized care patients
Type: Journal Article
Authors: J. I. Castro-Rodriguez, E. Olariu, C. Garnier-Lacueva, L. M. Martin-Lopez, V. Perez-Sola, J. Alonso, C. G. Forero, INSAyD investigators
Year: 2014
Topic(s):
General Literature See topic collection
3090
Diagnostic accuracy of a two-item Drug Abuse Screening Test (DAST-2)
Type: Journal Article
Authors: Q. Q. Tiet, Y. E. Leyva, R. H. Moos, B. Smith
Year: 2017
Publication Place: England
Abstract: OBJECTIVE: Drug use is prevalent and costly to society, but individuals with drug use disorders (DUDs) are under-diagnosed and under-treated, particularly in primary care (PC) settings. Drug screening instruments have been developed to identify patients with DUDs and facilitate treatment. The Drug Abuse Screening Test (DAST) is one of the most well-known drug screening instruments. However, similar to many such instruments, it is too long for routine use in busy PC settings. This study developed and validated a briefer and more practical DAST for busy PC settings. METHOD: We recruited 1300 PC patients in two Department of Veterans Affairs (VA) clinics. Participants responded to a structured diagnostic interview. We randomly selected half of the sample to develop and the other half to validate the new instrument. We employed signal detection techniques to select the best DAST items to identify DUDs (based on the MINI) and negative consequences of drug use (measured by the Inventory of Drug Use Consequences). Performance indicators were calculated. RESULTS: The two-item DAST (DAST-2) was 97% sensitive and 91% specific for DUDs in the development sample and 95% sensitive and 89% specific in the validation sample. It was highly sensitive and specific for DUD and negative consequences of drug use in subgroups of patients, including gender, age, race/ethnicity, marital status, educational level, and posttraumatic stress disorder status. CONCLUSIONS: The DAST-2 is an appropriate drug screening instrument for routine use in PC settings in the VA and may be applicable in broader range of PC clinics.
Topic(s):
Measures See topic collection
,
Opioids & Substance Use See topic collection
3091
Dialing for doctors: Secret shopper study of Arizona methadone and buprenorphine providers, 2022
Type: Journal Article
Authors: B. E. Meyerson, D. Treiber, B. R. Brady, K. Newgass, K. Bondurant, K. G. Bentele, S. Samorano, C. Arredondo, N. Stavros
Year: 2024
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
3092
DIAMOND for Depression
Type: Web Resource
Authors: Institute for Clinical Systems Improvement
Year: 2013
Topic(s):
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

3093
Diamorphine assisted treatment in Middlesbrough: a UK drug treatment case study
Type: Journal Article
Authors: Hannah Louise Poulter, Helen Moore, Rob Crow, Danny Ahmed, Tammi Walker
Year: 2024
Topic(s):
Opioids & Substance Use See topic collection
3094
Did Arkansas' Medicaid Patient-Centered Medical Home Program Have Spillover Effects on Commercially Insured Enrollees?
Type: Journal Article
Authors: Jesse M. Hinde, Nathan West, Samuel J. Arbes III, Marianne Kluckman, Suzanne L. West
Year: 2020
Publication Place: Thousand Oaks, California
Topic(s):
Education & Workforce See topic collection
,
Financing & Sustainability See topic collection
,
Medical Home See topic collection
3095
Differences between soldiers, with and without emotional distress, in number of primary care medical visits and type of presenting complaints
Type: Journal Article
Authors: A. D. Heymann, Y. Shilo, A. Tirosh, L. Valinsky, S. Vinker
Year: 2007
Publication Place: Israel
Abstract: BACKGROUND: In 2003 a total of 43 soldiers in the Israel Defense Forces committed suicide; only 20% of them were known to the IDF mental health services. Somatic symptoms are often the only presentation of emotional distress during the primary care visit and may be the key to early identification and treatment. OBJECTIVES: To examine whether the information in the medical records of soldiers can be used to identify those suffering from anxiety, affective or somatoform disorder. METHODS: We conducted a case-control study using the information in the electronic medical records of soldiers who during their 3 year service developed affective disorder, anxiety, or somatoform disorder. A control group was matched for recruitment date, type of unit and occupation in the service, and the Performance Prediction Score. The number and reasons for physician visits were collated. RESULTS: The files of 285 soldiers were examined: 155 cases and 130 controls. The numbers of visits (mean +/- SD) during the 3 and 6 month periods in the case and control groups were 4.7 +/- 3.3 and 7.1 +/- 5.0, and 4.1 +/- 2.9 and 5.9 +/- 4.6 respectively. The difference was statistically significant only for the 6 month period (P < 0.05). The variables that remained significant, after stepwise multivariate regression were the Performance Prediction Score and the presenting complaints of back pain and diarrhea. CONCLUSIONS: These findings may spur the development of a computer-generated warning for the primary care physician who will then be able to interview his or her patient appropriately and identify mental distress earlier.
Topic(s):
HIT & Telehealth See topic collection
3096
Differences in buprenorphine prescribing readiness among primary care professionals with and without X-waiver training in the US
Type: Journal Article
Authors: B. Franz, L . Y. Dhanani, O. T. Hall, D. L. Brook, J. E. Simon, W. C. Miller
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
,
Education & Workforce See topic collection
,
Healthcare Policy See topic collection
3097
Differences in Medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009-2018
Type: Journal Article
Authors: O. K. Golan, F. Sheng, A. W. Dick, M. Sorbero, D. J. Whitaker, B. Andraka-Christou, T. Pigott, A. J. Gordon, B. D. Stein
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Policy See topic collection
,
Financing & Sustainability See topic collection
,
Healthcare Disparities See topic collection
3098
Differences in medical care expenditures for adults with depression compared to adults with major chronic conditions
Type: Journal Article
Authors: I. Z. Lurie, L. M. Manheim, D. D. Dunlop
Year: 2009
Publication Place: Italy
Abstract: BACKGROUND: Approximately 17.1 million adults report having a major depressive episode in 2004 which represents 8% of the adult population in the U.S. Of these, more than one-third did not seek treatment. In spite of the large and extensive literature on the cost of mental health, we know very little about the differences in out-of-pocket expenditures between adults with depression and adults with other major chronic disease and the sources of those expenditures. AIMS: For persons under age 65, compare total and out-of-pocket expenditures of those with depression to non-depressed individuals who have another major chronic disease. METHODS: This study uses two linked, nationally representative surveys, the 1999 National Health Interview Survey (NHIS) and the 2000 Medical Expenditure Panel Survey (MEPS), to identify the population of interest. Depression was systematically assessed using a short form of the World Health Organization's (WHO) Composite International Diagnostic Interview--Short Form (CIDI-SF). To control for differences from potentially confounding factors, we matched depressed cases to controls using propensity score matching. RESULTS: We estimate that persons with depression have about the same out-of-pocket expenditures while having 11.8% less total medical expenditures (not a statistically significant difference) compared to non-depressed individuals with at least one chronic disease. DISCUSSION: High out-of-pocket expenditures are a concern for individuals with chronic diseases. Our study shows that those with depression have comparable out-of-pocket expenses to those with other chronic diseases, but given their lower income levels, this may result in a more substantial financial burden. IMPLICATION FOR POLICY: High out-of-pocket expenditures are a concern for individuals with depression and other chronic diseases. For both depressed individuals and non-depressed individuals with other chronic diseases, prescription drug expenditures contribute most to out-of-pocket expenses. Given the important role medications play in treatment of depression, high copayment rates are a concern for limiting compliance with appropriate treatment.
Topic(s):
Financing & Sustainability See topic collection
,
Key & Foundational See topic collection
3099
Differences in patients' perceived helpfulness of depression treatment provided by general medical providers and specialty mental health providers
Type: Journal Article
Authors: S. J. Kuramoto-Crawford, B. Han, L. Jacobus-Kantor, R. Mojtabai
Year: 2015
Publication Place: United States
Abstract: OBJECTIVE: This study examined the differences in the level of perceived helpfulness of treatments received for a major depressive episode (MDE) from a general medical provider only, a specialty mental health provider only or both. METHOD: This study examined a sample of 8900 respondents from the 2008-2012 National Survey on Drug Use and Health aged 18-64 who had past 12-month MDE (based on criteria specified in the Diagnostic and Statistical Manual of Mental Disorders, Fourth edition) and received treatment for depression. Generalized ordered logistic regression analyses were conducted to estimate the association between the type of treatment providers and perceived helpfulness of depression treatment. RESULTS: Adults who received depression treatment from either specialty mental health providers alone or from both specialty mental health providers and general medical providers in the past year were more likely to report that treatment helped them. The differences persisted after adjusting for sociodemographic characteristics, comorbid health conditions, receipt of depression medication and severity of depression (adjusted odds ratios across level of perceived helpfulness ranged from 1.63 to 3.96). CONCLUSIONS: This finding calls for greater attention to factors associated with provider type and organizational context that may contribute to differences in perceived helpfulness of depression treatment.
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
3100
Differences in perceived clinical knowledge uptake among health profession students and licensed clinicians receiving buprenorphine waiver training in Oregon
Type: Journal Article
Authors: J. L. Robbins, K. Bonuck, P. Thuillier, C. Buist, P. A. Carney
Year: 2022
Publication Place: United States
Abstract:

Background: Addressing the opioid crisis requires an understanding of how to train both health professional students and practicing clinicians on medications for opioid use disorder (mOUD). We designed a robust evaluation instrument to assess the impact of training on perceived clinical knowledge in these different categories of learners. Methods: We enrolled 3rd and 4th year medical, physician assistant (PA), and nurse practitioner (NP) students, as well as practicing PAs, NPs, and physicians to undertake the Drug Addiction Treatment Act (DATA) Waiver Training for mOUD. We designed and implemented a cross-sectional survey to assess perceived change in clinical knowledge as a result of training in opioid use disorder and satisfaction with training. Results: Twenty-one MD/DO and 45 NP/PA students, and 24 practicing MD/DO and 27 NP/PAs completed the survey. Among health professional students (n = 66) and practicing clinicians (n =51), perceived clinical knowledge scores increased significantly (p < 0.001) for all 13 variables. Program evaluation scores for the buprenorphine waiver training were high with no statistical differences between students and practicing clinicians. Overall, the majority of participants indicated they would recommend the training to a colleague (Students' score = 4.84; practicing clinician scores = 4.53; scale = strongly disagree = 1 to strongly agree = 5). Conclusions: Our novel instrument allowed us to determine that the implementation of buprenorphine waiver trainings for health professional students and practicing clinicians leads to significant increases in perceived knowledge, interest and confidence in diagnosing and treating OUD. Although the buprenorphine waiver can now be obtained without training, many waivered providers still do not prescribe buprenorphine; integrating training into medical, NP, and PA curriculum for students and offering the training to practicing clinicians may increase confidence and uptake of mOUD.

Topic(s):
Education & Workforce See topic collection
,
Measures See topic collection
,
Opioids & Substance Use See topic collection